untitled letter

FDA
Marketing

FDA dings Evolus for blurred lines between Botox rival, lipstick

The FDA warned Evolus over an Instagram reel that made the “especially problematic” suggestion of blurred lines between Jeuveau and cosmetics.
Nick Paul Taylor Oct 5, 2026 5:35am
FDA

FDA dings Alar over ‘extremely concerning’ ketamine claims

Aug 31, 2026 3:46pm
FDA

Viatris runs into FDA roadblock over on-the-go inhaler claim

Jul 30, 2026 6:57am
Sanofi

Sanofi gets FDA untitled letter over Beyfortus promotional emails

Jul 22, 2026 2:42pm
stack of letters mail envelopes

Lundbeck hit with untitled letter over Vyepti efficacy claims

Jul 8, 2026 4:23pm
FDA

FDA finds fault with Pinnacle’s photodynamic therapy videos

Jun 25, 2026 10:12am